Naureen Quibria
Stock Analyst at Capital One
(n/a)
# 4,707
Out of 5,152 analysts
8
Total ratings
11.11%
Success rate
-44.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Naureen Quibria
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Initiates: Overweight | $25 | $1.37 | +1,724.82% | 1 | Aug 29, 2024 | |
| IMMP Immutep | Initiates: Overweight | $10 | $2.76 | +262.32% | 1 | May 17, 2024 | |
| ERAS Erasca | Initiates: Overweight | $8 | $15.54 | -48.52% | 1 | Mar 11, 2024 | |
| IMCR Immunocore Holdings | Initiates: Overweight | $84 | $31.98 | +162.66% | 1 | Aug 16, 2023 | |
| DAWN Day One Biopharmaceuticals | Initiates: Overweight | $40 | $12.78 | +212.99% | 1 | Feb 8, 2023 | |
| FENC Fennec Pharmaceuticals | Initiates: Overweight | $11 | $7.93 | +38.71% | 1 | Sep 7, 2022 | |
| GNTA Genenta Science | Initiates: Buy | $21 | $0.91 | +2,215.58% | 1 | Jan 13, 2022 | |
| KZIA Kazia Therapeutics | Initiates: Buy | $900 | $8.62 | +10,346.89% | 1 | Oct 14, 2021 |
Biomea Fusion
Aug 29, 2024
Initiates: Overweight
Price Target: $25
Current: $1.37
Upside: +1,724.82%
Immutep
May 17, 2024
Initiates: Overweight
Price Target: $10
Current: $2.76
Upside: +262.32%
Erasca
Mar 11, 2024
Initiates: Overweight
Price Target: $8
Current: $15.54
Upside: -48.52%
Immunocore Holdings
Aug 16, 2023
Initiates: Overweight
Price Target: $84
Current: $31.98
Upside: +162.66%
Day One Biopharmaceuticals
Feb 8, 2023
Initiates: Overweight
Price Target: $40
Current: $12.78
Upside: +212.99%
Fennec Pharmaceuticals
Sep 7, 2022
Initiates: Overweight
Price Target: $11
Current: $7.93
Upside: +38.71%
Genenta Science
Jan 13, 2022
Initiates: Buy
Price Target: $21
Current: $0.91
Upside: +2,215.58%
Kazia Therapeutics
Oct 14, 2021
Initiates: Buy
Price Target: $900
Current: $8.62
Upside: +10,346.89%